SASHIDHAR NARAPA REDDY
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology ALLEN, TX NPI 1467535484
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology TX Tempus AI, Inc All categories
General Payments — all program years on this page
$4,552.86
- Category: General Payments
- Program years: PY2018–2024
- Record count: 164
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,002.83 across 40 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,002.83 | 40 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Tempus AI, Inc | $103.55 | 2 |
| Acerta Pharma LLC | $69.34 | 3 |
| JAZZ PHARMACEUTICALS INC. | $69.15 | 2 |
| Gilead Sciences, Inc. | $59.60 | 3 |
| E.R. Squibb & Sons, L.L.C. | $57.57 | 3 |
| Merck Sharp & Dohme Corporation | $53.46 | 2 |
| PFIZER INC. | $52.47 | 3 |
| Janssen Biotech, Inc. | $47.75 | 2 |
| Astellas Pharma US Inc | $46.69 | 2 |
| EISAI INC. | $45.84 | 2 |
| Sirtex Medical Inc | $45.16 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.31 | 1 |
| Celgene Corporation | $40.30 | 2 |
| GENZYME CORPORATION | $33.97 | 1 |
| Pharmacosmos Therapeutics Inc. | $33.75 | 1 |
| PharmaEssentia USA Corporation | $31.21 | 1 |
| Deciphera Pharmaceuticals Inc. | $25.02 | 1 |
| Incyte Corporation | $24.46 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.90 | 1 |
| TAIHO ONCOLOGY, INC. | $21.86 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.46 | 1 |
| Karyopharm Therapeutics Inc. | $19.93 | 1 |
| ABBVIE INC. | $19.73 | 1 |
| EMD Serono, Inc. | $16.35 | 1 |
By program year
Records — PY2024 (40)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.